Interactive Financial Charts Not Available

Royal Sense (ROYAL) | Financial Analysis & Statements

Royal Sense Ltd. | Small-cap | Healthcare

₹244.90

-1.25%

Royal Sense vs Entero Healthcare Royal Sense vs Amwill Health Care Royal Sense vs NOVELIX Royal Sense vs Trimurthi Royal Sense vs Zenlabs Ethica Royal Sense vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Sep 2023

Income Metrics

Revenue 33.9M

Gross Profit 5.3M 15.60%

Operating Income 2.6M 7.66%

Net Income 2.0M 5.79%

Balance Sheet Metrics

Total Assets 240.3M

Total Liabilities 34.4M

Shareholders Equity 205.9M

Debt to Equity 0.17

Cash Flow Metrics

Operating Cash Flow 50.9M

Free Cash Flow 26.6M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Royal Sense Income Statement From 2022 to 2025

Metric	2025	2024	2024	2023	2022
Revenue i	617.3M	220.2M	178.0M	0	67.5M
Cost of Goods Sold i	495.7M	182.4M	146.3M	0	61.5M
Gross Profit i	121.6M	37.8M	31.7M	0	6.0M
Gross Margin % i	19.7%	17.2%	17.8%	0.0%	8.8%
Operating Expenses
Research & Development i	-	-	-	-	-
Selling, General & Administrative i	9.6M	-	1.6M	1.5M	99.0K
Other Operating Expenses i	5.0M	3.3M	1.2M	532.0K	2.2M
Total Operating Expenses i	14.6M	3.3M	2.8M	2.0M	2.3M
Operating Income i	88.7M	31.8M	23.1M	0	2.2M
Operating Margin % i	14.4%	14.4%	13.0%	0.0%	3.2%
Non-Operating Items
Interest Income i	787.0K	-	304.0K	4.0K	25.0K
Interest Expense i	1.4M	381.0K	626.0K	0	0
Other Non-Operating Income	-	-	-	-	-
Pre-tax Income i	87.3M	31.8M	22.0M	0	2.2M
Income Tax i	24.0M	8.0M	6.1M	0	0
Effective Tax Rate % i	27.5%	25.2%	27.7%	0.0%	0.0%
Net Income i	63.3M	23.8M	15.9M	0	2.2M
Net Margin % i	10.3%	10.8%	8.9%	0.0%	3.2%
Key Metrics
EBITDA i	89.0M	32.2M	22.7M	0	2.3M
EPS (Basic) i	-	₹4.85	₹3.24	₹0.00	₹0.45
EPS (Diluted) i	-	₹4.85	₹3.24	₹0.00	₹0.45
Basic Shares Outstanding i	-	4898969	4900146	4900146	4900146
Diluted Shares Outstanding i	-	4898969	4900146	4900146	4900146

Income Statement Trend

Royal Sense Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	112.5M	87.4M	16.2M	259.0K	1.1M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	145.6M	32.2M	51.4M	12.9M	5.0M
Inventory i	57.5M	41.5M	4.0M	409.0K	1.7M
Other Current Assets	753.0K	267.0K	-	2.0K	-1.0K
Total Current Assets i	333.5M	201.8M	73.2M	15.6M	10.5M
Non-Current Assets
Property, Plant & Equipment i	0	0	-	-	-
Goodwill i	215.0K	52.0K	6.0K	7.0K	10.0K
Intangible Assets i	215.0K	52.0K	6.0K	7.0K	10.0K
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	-1.0K	11.0K	-	-1.0K	-1.0K
Total Non-Current Assets i	22.1M	5.9M	545.0K	406.0K	1.7M
Total Assets i	355.6M	207.7M	73.7M	16.0M	12.2M
Liabilities
Current Liabilities
Accounts Payable i	12.5M	262.0K	34.0M	6.2M	6.6M
Short-term Debt i	31.5M	13.8M	5.2M	3.2M	0
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	8.8M	1.0K	-	-	1.0K
Total Current Liabilities i	76.3M	23.3M	40.6M	9.5M	7.4M
Non-Current Liabilities
Long-term Debt i	1.0M	2.2M	-	-	-
Deferred Tax Liabilities i	30.0K	3.0K	0	0	0
Other Non-Current Liabilities	1.0K	-1.0K	1.0K	-	-
Total Non-Current Liabilities i	1.9M	2.2M	1.0K	0	0
Total Liabilities i	78.3M	25.5M	40.6M	9.5M	7.4M
Equity
Common Stock i	49.7M	49.0M	33.1M	6.5M	4.8M
Retained Earnings i	79.2M	15.9M	0	0	0
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	277.4M	182.2M	33.1M	6.5M	4.8M
Key Metrics
Total Debt i	32.6M	16.0M	5.2M	3.2M	0
Working Capital i	257.2M	178.5M	32.6M	6.1M	3.1M

Balance Sheet Composition

Royal Sense Cash Flow Statement From 2022 to 2025

Metric	2025	2024	2024	2023	2022
Operating Activities
Net Income i	87.3M	31.8M	22.0M	13.2M	2.2M
Depreciation & Amortization i	-	-	-	-	-
Stock-Based Compensation i	-	-	-	-	-
Working Capital Changes i	-83.5M	-81.2M	-40.7M	-37.5M	-3.6M
Operating Cash Flow i	5.2M	-49.4M	-18.4M	-24.0M	-1.4M
Investing Activities
Capital Expenditures i	-16.2M	-161.0K	-335.0K	0	0
Acquisitions i	0	0	249.0K	0	-
Investment Purchases i	-50.0K	-10.8M	-4.0M	-193.0K	-
Investment Sales i	-	-	-	-	795.0K
Investing Cash Flow i	-16.4M	-10.9M	-5.2M	-193.0K	1.3M
Financing Activities
Share Repurchases i	-	-	-	-	-
Dividends Paid i	-	-	-	-	-
Debt Issuance i	-	-	-	-	-
Debt Repayment i	-1.2M	-	0	-	-
Financing Cash Flow i	30.8M	0	155.5M	13.4M	-486.0K
Free Cash Flow i	-4.1M	-45.8M	-39.1M	0	-1.6M
Net Change in Cash i	19.6M	-60.3M	131.9M	-10.7M	-612.0K

Cash Flow Trend

Royal Sense Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 20.96

Price to Book 4.44

Price to Sales 2.15

Profitability Ratios

Profit Margin 10.26%

Operating Margin 12.41%

Return on Equity 27.55%

Return on Assets 19.68%

Financial Health

Current Ratio 4.37

Debt to Equity 11.74

Per Share Data

EPS (TTM) ₹11.83

Book Value per Share ₹55.83

Revenue per Share ₹124.26

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
royal	1.4B	20.96	4.44	27.55%	10.26%	11.74
Entero Healthcare	49.3B	48.24	2.86	5.36%	1.90%	21.76
Amwill Health Care	1.1B	7.86	1.51	24.85%	26.44%	0.00
NOVELIX	595.8M	65.57	2.27	0.48%	1.04%	0.00
Trimurthi	398.0M	102.35	-	0.00%	3.73%	-
Zenlabs Ethica	212.2M	78.92	1.96	2.58%	0.52%	121.85

Financial data is updated regularly. All figures are in the company's reporting currency.